Microglial Activation Pathway

The "microglial activation pathway" encompasses the cellular and molecular events that drive microglia, the brain's resident macrophages, from a surveillant/resting state into various activated or reactive states in response to stimuli such as injury, infection, or neurodegenerative signals. Multiple receptor-mediated pathways (e.g., Toll-like receptors, cytokine receptors) and intracellular signaling cascades (e.g., NF-κB, JAK/STAT, MAPK, Notch, PI3K/Akt) are involved, leading to either pro-inflammatory (M1) or anti-inflammatory/tissue repair (M2) responses[1][2][3][4][5][6][7][9]. Aberrant or chronic activation is implicated in the pathogenesis of neurodegenerative diseases such as Alzheimer's, Parkinson's, and multiple sclerosis[1][2][6][9]. Therapeutic strategies aim to modulate microglial activation by promoting protective phenotypes or inhibiting harmful ones, often by targeting key components within these activation pathways[2][3][6][9]. The term "microglial activation pathway" is too broad and non-specific; it should not be treated as a single druggable target, enzyme, or receptor but rather as a summary term for a set of intracellular and extracellular mechanisms relevant to neuroimmunology and neuroinflammation research[1][2][3][5][7].

Other names

Microglia activationmicroglial response pathwaymicroglial polarization

Promoting M2 phenotype (anti-inflammatory), Suppressing M1 phenotype (pro-inflammatory), Inhibition of JAK/STAT pathway, HDAC inhibition, PPARγ activation